286 related articles for article (PubMed ID: 36674836)
21. Pyrvinium attenuates Hedgehog signaling downstream of smoothened.
Li B; Fei DL; Flaveny CA; Dahmane N; Baubet V; Wang Z; Bai F; Pei XH; Rodriguez-Blanco J; Hang B; Orton D; Han L; Wang B; Capobianco AJ; Lee E; Robbins DJ
Cancer Res; 2014 Sep; 74(17):4811-21. PubMed ID: 24994715
[TBL] [Abstract][Full Text] [Related]
22. A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO Inhibitors.
Rahman MM; Hazan A; Selway JL; Herath DS; Harwood CA; Pirzado MS; Atkar R; Kelsell DP; Linton KJ; Philpott MP; Neill GW
Cancer Res; 2018 May; 78(10):2577-2588. PubMed ID: 29463581
[TBL] [Abstract][Full Text] [Related]
23. Targeting the Hedgehog pathway with novel Gli1 hydrophobic tagging degraders.
Li X; Sun R; Wu H; Zheng C; Long YQ
Bioorg Chem; 2023 Sep; 138():106649. PubMed ID: 37307715
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Hedgehog Signaling in Fibroblasts, Pancreatic, and Lung Tumor Cells by Oxy186, an Oxysterol Analogue with Drug-Like Properties.
Wang F; Stappenbeck F; Parhami F
Cells; 2019 May; 8(5):. PubMed ID: 31137846
[TBL] [Abstract][Full Text] [Related]
25. Hedgehog-GLI signaling inhibition suppresses tumor growth in squamous lung cancer.
Huang L; Walter V; Hayes DN; Onaitis M
Clin Cancer Res; 2014 Mar; 20(6):1566-75. PubMed ID: 24423612
[TBL] [Abstract][Full Text] [Related]
26. Sonic hedgehog pathway for the treatment of inflammatory diseases: implications and opportunities for future research.
Palla M; Scarpato L; Di Trolio R; Ascierto PA
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35710292
[TBL] [Abstract][Full Text] [Related]
27. Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures.
Cohen JR; Resnick DZ; Niewiadomski P; Dong H; Liau LM; Waschek JA
BMC Cancer; 2010 Dec; 10():676. PubMed ID: 21143927
[TBL] [Abstract][Full Text] [Related]
28. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.
Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW
J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713
[TBL] [Abstract][Full Text] [Related]
29. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
[TBL] [Abstract][Full Text] [Related]
30. GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas.
Atwood SX; Li M; Lee A; Tang JY; Oro AE
Nature; 2013 Feb; 494(7438):484-8. PubMed ID: 23446420
[TBL] [Abstract][Full Text] [Related]
31. Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers.
Katoh M
Clin Sci (Lond); 2019 Apr; 133(8):953-970. PubMed ID: 31036756
[TBL] [Abstract][Full Text] [Related]
32. CCL2/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the Hedgehog pathway.
Zhuang H; Cao G; Kou C; Liu T
Oncol Rep; 2018 Jan; 39(1):21-30. PubMed ID: 29115520
[TBL] [Abstract][Full Text] [Related]
33. Nonclassical hedgehog-GLI signaling and its clinical implications.
Shevde LA; Samant RS
Int J Cancer; 2014 Jul; 135(1):1-6. PubMed ID: 23929208
[TBL] [Abstract][Full Text] [Related]
34. Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma.
Chen B; Trang V; Lee A; Williams NS; Wilson AN; Epstein EH; Tang JY; Kim J
Mol Cancer Ther; 2016 May; 15(5):866-76. PubMed ID: 26823493
[TBL] [Abstract][Full Text] [Related]
35. Gant61 ameliorates CCl
Jiayuan S; Junyan Y; Xiangzhen W; Zuping L; Jian N; Baowei H; Lifang J
Toxicol Appl Pharmacol; 2020 Jan; 387():114853. PubMed ID: 31816328
[TBL] [Abstract][Full Text] [Related]
36. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W
Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
[TBL] [Abstract][Full Text] [Related]
37. Nonclassical activation of Hedgehog signaling enhances multidrug resistance and makes cancer cells refractory to Smoothened-targeting Hedgehog inhibition.
Das S; Samant RS; Shevde LA
J Biol Chem; 2013 Apr; 288(17):11824-33. PubMed ID: 23508962
[TBL] [Abstract][Full Text] [Related]
38. Targeting GLI factors to inhibit the Hedgehog pathway.
Infante P; Alfonsi R; Botta B; Mori M; Di Marcotullio L
Trends Pharmacol Sci; 2015 Aug; 36(8):547-58. PubMed ID: 26072120
[TBL] [Abstract][Full Text] [Related]
39. The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma.
Lospinoso Severini L; Ghirga F; Bufalieri F; Quaglio D; Infante P; Di Marcotullio L
Expert Opin Ther Targets; 2020 Nov; 24(11):1159-1181. PubMed ID: 32990091
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of Hedgehog signalling in cancer.
Marini KD; Payne BJ; Watkins DN; Martelotto LG
Growth Factors; 2011 Dec; 29(6):221-34. PubMed ID: 21875383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]